Oliviero James F III
SEC CIK 1434718 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVCT | Nuvectis Pharma, Inc. | Dir | 122.8K | — | — | 4 | 2023-06-16 | 2026-06-11 |
Most active insiders at NVCT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mosseri Marlio Charles | 10% | $1.87M | — |
| 2 | BENTSUR RON | COB, CEO, Dir, 10% | $278.6K | — |
| 3 | Sanchez Juan | Dir | $75.3K | — |
| 4 | Kaplan Matthew L. | Dir | $64.2K | — |
| 5 | Poradosu Enrique | Chief Science, Business Off | — | — |
| 6 | Carson Michael J. | VP, Fin | — | — |
| 7 | Shemesh Shay | Chief Dev, Ops. Off | — | — |
| 8 | Hoberman Kenneth | Dir | — | — |
| 9 | Oliviero James F III | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-12 16:11 | 2026-06-11 | NVCT | Nuvectis Pharma, Inc. | Oliviero James F III | Dir | A - Grant | $0.00 | +35.0K | 122.8K | +40% | $0 | |
| 2025-06-12 | 2025-06-12 | NVCT | Nuvectis Pharma, Inc. | Oliviero James F III | Dir | A - Grant | $0.00 | +30.0K | 87.8K | +52% | $0 | |
| 2024-06-13 | 2024-06-13 | NVCT | Nuvectis Pharma, Inc. | Oliviero James F III | Dir | A - Grant | $0.00 | +30.0K | 57.8K | +108% | $0 | |
| 2023-06-20 | 2023-06-16 | NVCT | Nuvectis Pharma, Inc. | Oliviero James F III | Dir | A - Grant | $0.00 | +18.0K | 27.8K | +183% | $0 |
Purchase Sale Sale after option exercise All abbreviations